During the past decade, Klinikum Oldenburg conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 12 clinical trials were completed, i.e. on average, 27.9% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 8 clinical trials were completed. i.e. 42.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Oldenburg" #1 sponsor was "German CLL Study Group" with 6 trials, followed by "University of Ulm" with 6 trials sponsored, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 5 trials sponsored, "Goethe University" with 5 trials sponsored and "Abbott Medical Devices" with 5 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Oldenburg" #1 collaborator was "Deutsche Kinderkrebsstiftung" with 4 trials as a collaborator, "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 3 trials as a collaborator, "Arbeitsgemeinschaft Pädiatrische Radioonkologie (APRO)" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Cancer Trials Ireland" with 2 trials as a collaborator. Other collaborators include 63 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Oldenburg" are "Lymphoma" (8 trials), "Acute Myeloid Leukemia" (6 trials), "Heart Failure" (5 trials), "Leukemia" (5 trials) and "Chronic Lymphocytic Leukemia" (4 trials). Many other conditions were trialed in "Klinikum Oldenburg" in a lesser frequency.

Most popular intervention types in "Klinikum Oldenburg" are "Drug" (61 trials), "Biological" (20 trials), "Device" (15 trials), "Radiation" (15 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (14 trials), "radiation therapy" (12 trials), "doxorubicin hydrochloride" (11 trials), "vincristine sulfate" (11 trials) and "filgrastim" (9 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Oldenburg" are 91 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Klinikum Oldenburg". undefined are not yet recruiting, 20 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 50 completed trials in Klinikum Oldenburg, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Oldenburg, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 17 trials that are defined as “Not Applicable".

Klinikum Oldenburg has several departments that took part in Clinical trials: "Medizinisches Versorgungszentrum am Klinikum Oldenburg GmbH" - 2 trials, "Klinikum Oldenburg AöR, Zentrum für Kinder- und Jugendmedizin, Abt. Hämatologie / Onkologie" - 2 trials